Skip to main
SYK

Stryker (SYK) Stock Forecast & Price Target

Stryker (SYK) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 56%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Stryker is poised for continued growth in the near term due to its strong position in the reconstructive orthopedic implants and operating room equipment market, as well as its recent acquisitions in the medical technology space. However, there are potential risks to the company's growth, including a potential slowdown in the growth contribution from its flagship products and potential competition from other players in the orthopedic robotics market. The recent cyberattack could also have a negative impact on SYK's first-quarter results, but the company expects to recover lost sales over the remainder of 2026. The international segment has outpaced the US segment, and positive pricing has been sustained overall. While there are some potential risks to our outlook, we believe that Stryker has the potential to sustain above-average revenue and EPS growth, and we view it as one of the best-positioned large-cap med tech companies.

Bears say

Stryker is facing increased competition in its robotic systems from several other companies, as well as uncertainty surrounding slower-than-expected adoption in the ASC setting. Additionally, the company's reliance on acquisitions for growth may pose a risk, and macroeconomic headwinds could further impact sales and earnings. These factors, combined with the stock's already high valuation, lead to a negative outlook on the stock.

Stryker (SYK) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 56% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stryker (SYK) Forecast

Analysts have given Stryker (SYK) a Buy based on their latest research and market trends.

According to 18 analysts, Stryker (SYK) has a Buy consensus rating as of Aug 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $391.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $391.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stryker (SYK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.